Skip to main content
PLOS One logoLink to PLOS One
. 2024 Nov 21;19(11):e0310305. doi: 10.1371/journal.pone.0310305

Investigation of the effectiveness of no-reference metric in image evaluation in nuclear medicine

Shigeaki Higashiyama 1,*,#, Yutaka Katayama 2,#, Atsushi Yoshida 1,#, Nahoko Inoue 3,#, Takashi Yamanaga 2,, Takao Ichida 2,, Yukio Miki 3,#, Joji Kawabe 1,#
Editor: Sadiq H Abdulhussain4
PMCID: PMC11581283  PMID: 39571042

Abstract

Background

In nuclear medicine, normalized mean square error (NMSE) is widely used for image quality evaluation and machine adjustment. However, evaluating clinical images in nuclear medicine using NMSE necessitates acquiring a reference image, which is time consuming and impractical. Therefore, it is necessary to explore no-reference metrics, such as perception-based image quality evaluator (PIQE) and natural image quality evaluator (NIQE), as alternatives for evaluating the quality of clinical images used in nuclear medicine.

Purpose

To examine whether no-reference metrics can be applied to image quality evaluations for clinical images in nuclear medicine.

Methods

Images of the Hoffman Brain Phantom containing 18F–fluoro-2-deoxy-D-glucose (FDG) were obtained using Biograph Vision (Siemens Co., Ltd). From the collected images, 14 images with varying pixel counts and acquisition times were created. Sixteen images were visually evaluated by five image experts and ranked accordingly. Image quality was assessed using NMSE, PIQE, and NIQE, and rankings were calculated based on these scores.

Results

The Spearman’s significance test revealed a strong correlation between image quality evaluations using PIQE and visual evaluations by specialists (p<0.0001). PIQE demonstrated comparable performance to image experts in evaluating image quality, suggesting its potential for clinical image quality assessment in nuclear medicine.

Conclusions

PIQE offers a viable method for evaluating image quality in nuclear medicine, presenting a promising alternative to traditional visual inspection methods.

Introduction

The advent of artificial intelligence (AI)-based image processing approaches, such as generative adversarial network (GAN)-based models, has sparked significant interest in image quality assessment [1, 2]. However, traditional full-reference metrics such as peak signal-to-noise ratio (PSNR) or structural similarity (SSIM) may not effectively evaluate images generated using GANs [3, 4]. In contrast, no-reference metrics offer a promising solution for evaluating image quality when a reference image is unavailable.

Although full-reference metrics are commonly used in medical image evaluation, particularly in nuclear medicine, their reliance on reference images limits their applicability in clinical settings [5]. Normalized mean square error (NMSE), a prevalent full-reference metric, requires a long-term captured reference image corresponding to the target image, making it impractical for clinical evaluations [68]. Additionally, the lack of common training and standard image data further complicates image evaluation in nuclear medicine [9, 10]. For positron emission tomography (PET) images, efforts such as quantitative imaging biomarkers and harmonization have been made to evaluate pixel values obtained from images captured using different devices as comparable indicators [11, 12]. However, these are primarily intended to use pixel values as quantitative biomarkers and do not achieve image standardization [13, 14]. To address these challenges, this study investigated the efficacy of no-reference metrics, specifically PIQE and NIQE, in evaluating image quality for clinical images in nuclear medicine [1517]. By comparing the results of no-reference metric evaluations with visual evaluations by specialists, we demonstrated the potential of these metrics in clinical practice.

Contributions and findings

  • We proposed using no-reference metrics, namely PIQE and NIQE, for the evaluation of image quality in clinical nuclear medicine.

  • We demonstrated a strong correlation between the results of PIQE and visual evaluation by specialists, indicating the potential of PIQE in clinical image quality assessment.

  • We confirmed the feasibility of utilizing no-reference metrics as alternative methods for image evaluation in nuclear medicine.

Materials and methods

Image acquisition method and analysis

The images were obtained using a Hoffman 3D brain phantom (Data Spectrum Co., Ltd) containing 26 MBq of 18F–fluoro-2-deoxy-D-glucose (FDG) with a 3D model and 1800 s of imaging time. The Images were collected according to the protocol for brain PET imaging distributed by the Japanese Society of Nuclear Medicine and the PET Nuclear Medicine Committee [18]. Biograph Vision 450(Siemens Co., Ltd.), used for clinical examination at our hospital, was used for imaging and data collection.

For this study, one axial image slice was selected from the acquired brain phantom images, depicting the frontal/temporal lobe and bilateral ventricles of the bilateral cerebral hemisphere and basal ganglia. Such images are commonly used in the study of brain PET images using phantoms [19, 20].

For evaluation, we prepared images with seven different acquisition times: 120, 180, 300, 360, 450, 600, and 900 s. The collection matrix for a total of eight seed collection times was 440-pixels. To assess images with different pixel counts, 880-pixel images (used for clinical examinations at our facility) corresponding to each of the eight acquisition times were generated. Images with varying acquisition times and pixel counts were created and extracted using Biograph Vision 450.

The imaging and image reconstruction conditions were as follows:

  • Pixel size: 0.825 × 0.825 mm

  • FOV: 363 mm

  • Slice thickness: 3 mm

  • Reconstruction conditions: Ordinary Poisson ordered-subsets expectation maximization with point-spread function and time-of-flight modeling of 214 ps

  • Random correction: Delayed coincidence measurement

  • Single scatter simulation

  • Subset: 5

  • Iteration: 8

  • Filter: all-pass

  • For 440-matrix size: 0.825 × 0.825 × 2 mm3

  • For 880-matrix size: 0.4125 × 0.4125 × 2 mm3

  • Computed tomography attenuation correction

  • 80 mAs

  • 120 kV

  • Slice thickness: 3 mm

  • Pitch: 0.55 mm

  • MATLAB (MathWorks Co., Ltd) was used to calculate the noise metric

  • JMP (SAS Japan Co., Ltd) was used for statistical analysis

Evaluator and image

Three qualified diagnostic radiologists and nuclear medicine specialists, along with four nuclear medicine technologists, were selected to visually evaluate the images. Among the four technologists, two had over 15 years of clinical experience in nuclear medicine, while the other two were inexperienced.

Fig 1 depicts an image captured at 1800 s; a total of eight images were captured with different acquisition times—120, 180, 300, 360, 450, 600, and 900 s. The pixel count of the image in Fig 1 is 440 s. Fig 2 displays eight images, each containing 880 matrix size, corresponding to each acquisition time shown in Fig 1.

Fig 1. A Hoffman 3D brain phantom with 26 MBq of 18F-fluoro-2-deoxy-D-glucose (FDG) with a 440-pixel matrix were obtained over 1800 s.

Fig 1

One slice of the axial image that depicts the frontal and temporal lobes, bilateral lateral ventricles, and basal ganglia was selected from the acquired brain phantom images. Images with different collection times (120, 180, 300, 360, 450, 600, and 900 s) were prepared with 326x188 pixels and RGB with 239K. A total of eight image types with different collection times and color scale are shown.

Fig 2. 880-pixel images corresponding to each of the eight imaging times and color scale are shown.

Fig 2

Images with different collection times were prepared with 326x188 pixels and RGB with 239K.

The following two items were defined as the visual evaluation criteria:

(1) A clear delineation of the basal ganglia limbus and its clear separation from the cerebral white and gray matter.

(2) Uniform accumulation of FDG in the basal ganglia and cerebral white matter.

Previous studies addressed image quality by quantifying "the contrast between gray-matter structures and a white matter structure" and determining "the sharpness of the gray/white-matter" [19, 20].

The aforementioned criteria were set to evaluate the sliced image used in this study. The evaluation method necessitated numerical ranking. Therefore, we employed a paired comparison method to rank the evaluations by the evaluator, referencing previous research [21].

Visual evaluation method

The paired comparison method was used for visual evaluation: two images were displayed on the left and right sides of a monitor. Among the total of 16 images, two were selected to ensure that the same image was not displayed. By pairing different images on the left and right sides, a total of 240 image types were prepared and displayed randomly. The evaluator was unaware of which two images would be presented. In Fig 3, a 440-pixel image acquired at 180 s displayed on the left, and a 880-pixel image acquired at 900 s is displayed on the right. Numbers corresponding to all the 240 images are shown in Fig 2, which serves as a score entry sheet. Fig 3 corresponds to square 29 in Fig 4.

Fig 3. An image presented to evaluators.

Fig 3

A 440-pixel at 180 s image and a 880-pixel at 900 s image are displayed on the left and right sides, respectively. An image presented to evaluators. On the left is a 440-pixel at 180 s image, and on the right is a 880-pixel at 900 s image. This image corresponds to square number 29 shown in Fig 2.

Fig 4. Evaluation sheet for the images (out of 240 images) presented to the evaluator.

Fig 4

When the evaluator records the score, the cell in Fig 2 is blank, and the score is entered for the left and right images compared using the pairwise method. The rating is the total score in the leftmost column and bottom row.

Fourteen evaluation score sheets (Fig 4) were prepared for the seven evaluators to assess items 1 and 2. The table in Fig 4 was not shown to the evaluators, who visually evaluated the 240 images displayed in a random order. If the image displayed on the right side was of better quality than that on the left side, one point was assigned to the cell in Fig 4 for that image.

As shown in Fig 3, if the image on the right showed more uniform accumulation of FDG in the basal ganglia and white matter, the cell in square 29 of the evaluation score sheet for item 2 was assigned a score of 1. Two images identical to Fig 3 were included in the presentation but arranged in opposite directions, that is, the 900 s image with 880 pixels was presented on the left side, and the 180 s image with 440 pixels was presented on the right side corresponding to square 212 in Fig 4. In this case, if the image on the left side was better, a score of 0 was assigned to square 212.

Previous reports have visually scored PET images with different acquisition times and the degree of glucose metabolism and malignancy in thyroid tumors on a 5-point scale [22, 23]. Based on these reports, we scored the images based on their acquisition times and pixel count.

When the evaluator recorded the score, it was entered for the left and right images compared using the pairwise method. For the displayed image, as shown in Fig 3, a score of 0 or 1 was recorded in the corresponding cell of Fig 4. This was performed for evaluation items 1 and 2.

Higher total scores in the rightmost column of Fig 4 represent better results. Additionally, lower total scores in the bottom row represent better results. These scores were totaled, and the average values were calculated to obtain the visual evaluation scores and ranks.

Evaluation of NMSE

For physical evaluation, we used a physical index based on the NMSE, which has been conventionally used to calculate the similarity between reference and target images. The ideal and acquired images were used as the reference and target images, respectively [24]. NMSE normalizes the target images using the maximum number of pixels. The smaller the calculated value, the closer it is to the ideal target image [24]. The computation is as shown in Eq 1.

NMSE=f(x)=(g(x,y)f(x,y))2f(x,y))2 (1)

where f(x, y) refers to the reference image, and g(x, y) refers to the target image.

The target image for 440-pixel images obtained with acquisition times of 120, 180, 300, 360, 450, 600, and 900 s was a 440-pixel image with an acquisition time of 1800 s. The NMSE for the images with seven other acquisition times was calculated. NMSE value was calculated for the 880-pixel images in the same manner.

Evaluation of no-reference metric

PIQE is a no-reference perception-based image quality evaluation method for real-world images. It uses the mean subtraction contrast normalization coefficient to calculate the image quality score [15]. The natural image quality evaluator (NIQE) is an existing blind image quality evaluation method that relies on opinion-based supervised learning to predict quality scores [25]. However, PIQE is an unsupervised method that does not require a learning model [15].

PIQE is inspired by the following principles of human perception of image quality. First, human visual attention is strongly directed to prominent points in an image or spatially active areas; this property is adapted by estimating distortions only in spatially prominent areas [8]. Second, local quality at the block/patch level is the overall quality of the image that humans perceive, and this property is addressed by calculating the distortion level at the local block level of size n × n, where n = 16 [15].

Fig 5 shows a block diagram of the proposed method. The input image was preprocessed, followed by a block-level analysis to identify the distortion [15]. Each distorted block was assigned a score based on the distortion type, and the block-level scores were then pooled to determine the overall image quality. In addition to the quality score, it also generates a spatial quality map that can be effectively used in other applications.

Fig 5. Block diagram of the proposed method.

Fig 5

The input image was subjected to a preprocessing step. A block-level analysis was performed to identify the distortion, and each distorted block was assigned a score based on the distortion type. The block-level scores were pooled to determine the overall image quality.

In contrast, NIQE uses only measurable deviations from statistical regularities observed in natural images to calculate image quality scores in a completely blind manner [25]. It builds a collection of "quality-aware" statistical features based on a simple and successful spatial domain natural scene statistics (NSS) model [26, 27].

The distorted image quality is expressed as a simple distance metric between the model statistic and distorted image statistic [17]. Lower PIQE and NIQE scores indicate better imaging evaluations [15, 25].

No-reference metrics do not require a reference image. Therefore, the image quality was evaluated using PIQE and NIQE for both the 440-pixel and 880-pixel images obtained with eight different acquisition times: 120, 180, 300, 360, 450, 600, 900, and 1800 s.

Spearman’s rank difference test was performed. It is used in studies comparing interpretation results from AI-based methods with those of experienced readers, and for the comparison between human observers and mathematical models such as the channelized Hotelling observer [28, 29]. The significance level was set at P < 0.05.

To demonstrate that there was no significant difference in the ranking of PIQE results, the differences in PIQW values for each rank from 1st to 16th were calculated, resulting in 13 values. These 13 data points were divided into three groups, and Mann–Whitney’s U test was performed on them. The significance level was set at P < 0.05.

Evaluation of uniformity

To assess uniformity, a Region of Interest (ROI) was set on each image subjected to visual evaluation, and pixel values were measured. ROIs was positioned at the medulla of the frontal, temporal, and occipital lobes, ensuring that one edge of the ROI could be measured without crossing the boundary between the cortex and medulla. Fig 6 shows the site of the ROIs setting. The arrow in Fig 6 indicate the location of the ROI in the frontal lobe, the double arrow indicates the location of the ROI in the temporal lobe, and the arrowhead indicates the location of the ROI in the occipital lobe. Referring to previous literature, the size of the ROI was set to 5 mm in diameter [30, 31].

Fig 6. Chart of region of interest (ROI) set to evaluate uniformity.

Fig 6

The arrow indicates the location of the ROI in the frontal lobe, the double arrow indicates the location of the ROI in the temporal lobe, and the arrowhead indicates the location of the ROI in the occipital lobe. Referring to previous literature, the size of the ROI was set to 5 mm in diameter.

Numerical evaluation was performed using the coefficient of variation (CV). CV was calculated for the images with each pixel count and acquisition time. The calculation is shown in Eq 2.

CV=σ/x¯×100, (2)

where σ is standard deviation (SD) and x¯ is average value.

Ethics statement

This study exclusively utilized phantom images and did not involve the use of clinical images or human imaging data. As such, there was no requirement for approval from the Ethics Committee. Furthermore, as patient image data were not utilized, no explanation or consent was sought from any patient.

Results

Results of visual evaluation

Tables 1 and 2 show the scores of the two items for each image from all raters, obtained using the paired comparison method. Evaluators 6 and 7, who were inexperienced, were excluded from the analysis as their results tended to differ from those of the other evaluators.

Table 1. Scores for items 1 and 2 from seven evaluators.

Evaluator 1 1 2 2 3 3 4 4 5 5 6 6 7 7
Evaluation Item 1 2 1 2 1 2 1 2 1 2 1 2 1 2
Target
440-120s Score 0 0 1 1 0 0 1 1 1 1 1 1 1 1
880-120s Score 1 1 1 1 0 0 0 0 0 0 0 0 0 0
440-180s Score 2 2 0 1 2 2 2 2 2 2 1 3 2 2
880-180s Score 3 3 3 3 3 3 3 3 3 3 2 2 3 3
440-300s Score 4 4 4 6 5 5 4 4 4 4 4 4 5 5
880-300s Score 5 5 5 5 5 5 5 5 5 5 4 4 5 5
440-360s Score 9 9 6 6 7 7 6 6 6 6 7 7 9 8
880-360s Score 8 8 8 8 6 6 7 7 7 7 4 6 8 7
440-450s Score 7 7 6 6 9 9 8 8 8 8 7 8 9 9
880-450s Score 8 8 9 9 8 8 9 9 9 9 7 9 10 10
440-600s Score 10 10 7 8 11 11 10 10 11 11 10 10 11 10
880-600s Score 12 12 11 11 10 11 11 11 11 11 10 11 11 11
440-900s Score 11 11 10 11 13 13 12 12 12 12 12 12 13 13
880-900s Score 12 12 13 13 13 13 12 12 13 13 13 13 12 13
440-1800s Score 14 14 12 13 15 15 13 13 13 13 13 15 15 15
880-1800s Score 15 15 15 15 15 15 15 15 14 14 14 15 15 15

Table 2. Scores for items 1 and 2 from seven evaluators.

Evaluator 1 1 2 2 3 3 4 4 5 5 6 6 7 7
Evaluation Item 1 2 1 2 1 2 1 2 1 2 1 2 1 2
Target
440-120s Score 15 15 14 14 14 14 14 14 14 14 13 14 14 13
880-120s Score 14 14 13 14 14 14 15 15 15 15 15 15 15 15
440-180s Score 13 13 14 14 13 13 13 13 13 13 12 12 12 13
880-180s Score 12 12 12 12 12 12 12 12 12 12 12 13 12 13
440-300s Score 11 11 11 11 11 11 11 11 11 11 9 10 10 11
880-300s Score 10 10 6 6 11 11 10 10 10 10 9 10 10 10
440-360s Score 8 8 11 9 8 8 9 9 9 9 6 7 9 7
880-360s Score 7 7 7 7 9 9 8 8 8 8 7 9 9 8
440-450s Score 8 7 7 8 6 6 7 7 7 7 7 7 8 8
880-450s Score 7 7 7 5 7 7 6 6 6 6 7 7 9 8
440-600s Score 8 5 5 5 5 5 5 5 5 5 4 5 6 7
880-600s Score 3 3 3 4 5 5 3 3 4 4 4 4 5 5
440-900s Score 4 4 3 3 3 3 2 2 3 3 1 3 3 3
880-900s Score 3 3 1 2 3 3 2 2 2 2 1 2 3 3
440-1800s Score 1 1 1 1 1 1 1 1 0 0 1 1 1 1
880-1800s Score 0 0 0 0 1 1 0 0 0 0 0 1 1 1

Fig 4 shows a scoring sheet for entering 0 and 1 to indicate the superiority of images in the paired comparison method. The bottom row of Fig 4 is a column for entering the sum of these numbers vertically for each image. Table 1 represents the results of that column. Higher scores represent better evaluation results. The rightmost column of Fig 4 is a column for entering the sum of these numbers horizontally for each image. Table 2 represents the results of that column. Lower scores represent better evaluation results.

The average visual evaluation results obtained using the pairwise comparison method for all items is shown in Table 3.

Table 3. Average scores for each image and their ranking from the five experienced evaluators.

Target image Average scores in descending order Average scores in ascending order Total ranks
880-1800s 14.8 0.2 1
440-1800s 13.5 0.8 2
880-900s 12.6 2.3 3
440-900s 11.7 3 4
880-600s 11.1 3.7 5
440-600s 9.9 5.3 6
880-450s 8.6 6.4 7
440-450s 7.6 7.1 8
880-360s 7.2 7.8 9
440-360s 6.8 8.8 10
880-300s 5 9.4 11
440-300s 4.4 11 12
880-180s 3 12 13
440-180s 1.7 13.2 14
880-120s 0.4 14.3 16
440-120s 0.6 14.2 15

The results for the 880-pixel images is shown in bold.

In Table 3, the scores of an 880-pixel image acquired at the specified shooting time are highlighted in bold. It was observed that for both the 880-pixel and 440-pixel images, higher scores were achieved with longer shooting times. Additionally, for images with acquisition times other than 120 s, a higher score was obtained when the number of pixels was 880.

Results of evaluation using NMSE

The target image for the 440-pixel and 880-pixel images obtained with acquisition times of 120, 180, 300, 360, 450, 600, and 900 s were images with an acquisition time of 1800 s and 440- and 880-pixels in size, respectively. The evaluation values for the images with seven other acquisition times were calculated using the NMSE. The results are shown in Tables 4 and 5.

Table 4. NMSE scores for seven images with 440 pixels.

Target image NMSE score Rank
440-900s 0.008389 1
440-600s 0.014692 2
440-450s 0.015165 3
440-360s 0.018685 4
440-300s 0.027426 5
440-180s 0.036682 6
440-120s 0.052736 7

NMSE: Normalized mean square error

Table 5. NMSE scores for seven images with 880 pixels.

Target image NMSE score Rank
880-900s 0.007257 1
880-600s 0.012808 2
880-450s 0.01455 3
880-360s 0.018592 4
880-300s 0.0262 5
880-180s 0.035974 6
880-120s 0.050524 7

NMSE: Normalized mean square error

Table 6 summarizes all the results and arranges them in the order of the NMSE score. For most images, the NMSE value improved and approached 0 as the acquisition time increased. Additionally, the physical evaluation results of images with 880 pixels were better than those of images with 440-pixels.

Table 6. NMSE scores for all 440- and 880-pixel images except for the 1800 s images and their ranking.

Target image NMSE score Rank
880-900s 0.007257 1
440-900s 0.008389 2
880-600s 0.012808 3
440-600s 0.014692 5
880-450s 0.01455 4
440-450s 0.015165 6
880-360s 0.018592 7
440-360s 0.018685 8
880-300s 0.0262 9
440-300s 0.027426 10
880-180s 0.035974 11
440-180s 0.036682 12
880-120s 0.050524 13
440-120s 0.052736 14

NMSE: Normalized mean square error

Results of evaluation using PIQE and NIQE

The results of the physical evaluation using PIQE are presented in Table 7. Images with a lower no-reference metric value, longer acquisition time, and 880 pixels showed better results. Spearman’s significance test of the visual evaluation results and PIQE rankings showed a rank correlation coefficient (rs) of 0.9559 (p < 0.0001), indicating a strong correlation between the two methods (Fig 7).

Table 7. PIQE scores and their ranking.

Target image PIQE score Rank
880-1800s 60.3786 1
440-1800s 60.7609 2
880-900s 62.7803 3
440-900s 65.3957 4
880-600s 66.0972 5
440-600s 69.7924 9
880-450s 67.1711 6
440-450s 72.1406 10
880-360s 68.1758 7
440-360s 72.5463 11
880-300s 68.1903 8
440-300s 72.7048 12
880-180s 74.1163 13
440-180s 75.5763 14
880-120s 77.4794 15
440-120s 79.5117 16

PIQE: Perception-based image quality evaluator

Fig 7. Correlation between the visual assessment and PIQE rankings.

Fig 7

PIQE: Perception-based image quality evaluator. Spearman’s significant difference test between the visual assessment and PIQE rankings revealed a rs of 0.9559 (p < 0.0001), indicating a strong correlation.

Lower scores represent better image quality.

Fig 8 shows the results of Mann–Whitney’s U test, where PIQE differences were divided into three groups based on numerical rankings. The rankings of PIQE were classified into three groups: group 1 consisted of the differences between 1st and 4th place, comprising three numbers; group 2 included the differences between 5th and 12th place, comprising seven numbers; and group 3 comprised the values from 13th to 16th place. No significant difference was observed among these groups. The P value, which is the test value for groups 1 and 2, was p = 0.3619, the P value for groups 2 and 3 was p = 0.175, and the P value for groups 1 and 3 was p = 0.833.

Fig 8. Significant difference examined in the ranking of PIQE.

Fig 8

The difference between the top and bottom ranks from 1st to 16th. The difference between 1st and 4th place was group 1, the difference between 5th and 12th place was group 2, and the difference between 13th and 16th place was group 3. There was no significant difference among the three groups.

Results of the physical evaluation using NIQE are also shown in Table 8. Spearman’s significance test of the visual evaluation and NIQE rankings yielded a rs of 0.2324 (p = 0.3865), indicating no significant correlation between the two methods (Fig 9).

Table 8. NIQE scores and their ranking.

Target image NIQE score Rank
880-1800s 6.6500 2
440-1800s 7.3372 11
880-900s 6.9129 8
440-900s 6.7181 4
880-600s 7.1605 10
440-600s 6.7528 5
880-450s 7.3985 12
440-450s 6.9369 9
880-360s 7.6248 13
440-360s 6.6778 3
880-300s 7.8463 14
440-300s 6.8895 7
880-180s 8.0195 15
440-180s 6.8434 6
880-120s 8.1071 16
440-120s 6.6168 1

NIQE: Natural Image Quality Evaluator; Lower scores represent better image quality.

Fig 9. Correlation between the visual assessment and NIQE rankings.

Fig 9

NIQE: natural image quality evaluator. Spearman’s significant difference test between the visual assessment and NIQE rankings revealed a rs of 0.2324 (p 0.3865), indicating no strong correlation between the two methods.

Results of the uniformity evaluation

Tables 911 shows the numerical results of the uniformity rating for the three areas: the frontal lobe, the temporal lobe, and the occipital lobe. Figs 1012 is a graph of the numerical results of Tables 911.

Table 9. Results of the uniformity evaluation medulla of the frontal lobe.

CV (440) CV (880)
440-60s 8.02 880-60s 8.48
440-120s 8.67 880-120s 9.20
440-180s 8.22 880-180s 8.49
440-300s 8.03 880-300s 7.52
440-360s 7.75 880-360s 7.2
440-450s 5.87 880-450s 5.24
440-600s 4.70 880-600s 4.19
440-900s 4.27 880-900s 3.79
440-1800s 2.98 880-1800s 2.65

CV: coefficient of variation; Uniformity was evaluated numerically using the ROI (5 mm in diameter) placed on the medulla of the frontal lobe.

Table 11. Results of the uniformity evaluation medulla of the occipital lobe.

CV (440) CV (880)
440-60s 23.71 880-60s 24.31
440-120s 9.63 880-120s 9.64
440-180s 7.52 880-180s 7.43
440-300s 8.01 880-300s 8.07
440-360s 7.88 880-360s 7.80
440-450s 7.09 880-450s 7.12
440-600s 6.41 880-600s 6.54
440-900s 5.14 880-900s 5.24
440-1800s 2.73 880-1800s 2.8

CV: coefficient of variation; Uniformity was evaluated numerically using the ROI (5 mm in diameter) placed on the medulla of the occipital lobe.

Fig 10. Graphical display of the results of Table 9.

Fig 10

Fig 12. Graphical display of the results of Table 11.

Fig 12

Fig 11. Graphical display of the results of Table 10.

Fig 11

Table 10. Results of the uniformity evaluation medulla of the temporal lobe.

CV (440) CV (880)
440-60s 20.95 880-60s 20.74
440-120s 9.73 880-120s 9.41
440-180s 7.04 880-180s 7.13
440-300s 6.37 880-300s 6.6
440-360s 4.89 880-360s 5.14
440-450s 5.40 880-450s 5.67
440-600s 4.79 880-600s 5.06
440-900s 4.10 880-900s 4.03
440-1800s 3.33 880-1800s 3.07

CV: coefficient of variation; Uniformity was evaluated numerically using the ROI (5 mm in diameter) placed on the medulla of the temporal lobe.

Discussion

In this study, we examined whether no-reference metrics can be applied for the quality evaluation of clinical images in nuclear medicine. The visual assessment of the images by five raters was compared with the NMSE, and a statistical correlation was determined. Evaluation using PIQE demonstrated a strong correlation with visual assessment, suggesting equivalence between these two methods.

The results ranked by evaluators 6 and 7 were inconsistent compared to the other evaluators. Consequently, their evaluations were excluded, underscoring the validity of the evaluators’ selection. This also underscores that the evaluation criteria are not easily applied by any evaluator.

Because NMSE evaluates the target image using a reference image, it is generally impossible to evaluate images with different numbers of pixels. In this study, images with different acquisition times were evaluated using NMSE scores, using different references for 880- and 440-pixel images.

From the PIQE results, if the proportion of statistical noise was approximately the same, higher resolution was associated with higher evaluation. This trend was also reflected in visual assessments, indicating the potential for objective evaluation of not only statistical noise but also resolution differences using PIQE. The images ranked 1st to 4th in the PIQE results in Table 7 are arranged in the correct order reflecting the acquisition time and the number of pixels. It also agrees with the results of visual evaluation in Table 1. The 13th to 16th low-quality images in Table 7 also reflect the acquisition time and the number of pixels. Although there is a ranking reversal between the 15th and 16th images in visual assessment, it pertains to a low-ranking image, typically not accepted in clinical imaging. The discrepancy in the visual evaluation ranking by the image experts is believed to be due to the unfamiliarity with low-resolution images. In the ranking of 5th to 12th from 880-600s to 440-300s, PIQE provided better results for images with a higher number of pixels compared to the acquisition time. Within this range, the images were arranged in order of acquisition time. Visual evaluation by an image expert revealed that the order of pixel count and acquisition time matched, unlike the results obtained from PIQE. It is considered that sharpness is prioritized over noise in this image quality range. Although there was a difference between the results of the visual evaluation and the PIQE ranking within this range, there was no significant difference in the ranking in the Spearman’s significance test, and it is considered that the PIQE has the same evaluation ability as the visual evaluation. In addition, we calculated the difference between the bottom and top rankings in PIQE values, that is, 880-1800s to 440-900s ranked 1st to 4th, 880-600s to 440-300s ranked 5th to 12th, and 880s-180s to 440-120s ranked 13th to 15th. Intergroup comparison was performed by Mann-Whitney’s U test in three groups, there was no significant difference among them. It is thought that PIQE demonstrated the capability to evaluate the image quality of the 880-600s to 440-300s, ranked 5th to 12th, at a level comparable to that of visual evaluation.

Uniformity was evaluated, and as shown in Figs 8, 9 and 10, both 440- and 880-pixel images proved that the longer the imaging time, the higher the uniformity of the image. The results were almost consistent with the visual evaluation.

Visual evaluation of images from 1800 to 180 s showed that a longer acquisition time resulted in better evaluation scores (Table 3). The results and rankings obtained using NMSE were similar (Table 6). For images with the same acquisition time, 880-pixel images scored better than 440-pixel images (Table 3).

For images with an acquisition time of 120 s, the difference in ranking between 440 and 880 pixels was less than 0.2 points, which is a much smaller difference compared with that of the other rankings; however, it reversed the visual evaluation rankings (Table 3).

Evaluators 4 and 5 evaluated the ranking of 440- and 880-pixel images with a 120 s acquisition time, reversing the rating order for items 1 and 2 (Tables 1 and 2). They were diagnostic radiologists with more than 10 years of clinical experience and nuclear medicine specialists. This evaluation reversed the average rankings for the 440- and 880-pixel images at 120 s. For item 1, both evaluators found that the boundary between the white matter and gray matter of the temporal lobe and the peripapillary thalamus was clearer in the 440-pixel image because it had a wider area without accumulation. For item 2, the 440-pixel image showed more uniform accumulation because of a denser accumulation in the frontotemporal white matter, thalamus, and caudate nucleus in general. Noisy images acquired at 120 s were not of optimal quality for use in clinical imaging.

The rankings obtained from visual evaluation and the no-reference metric method were compared by five evaluators. Generally, supervised methods outperform unsupervised methods [26]. However, when creating a dataset for supervised learning in nuclear medicine, which is not well standardized, generating a standard image is not easy [13, 14]. It is more realistic to perform a general-purpose quantitative evaluation using supervised learning rather than a target [13, 14]. In this study, PIQE, an unsupervised method that does not require training data to evaluate image quality, yielded better results [15, 27]. Moreover, since PIQE does not depend on training data, it is considered a less environmentally dependent metric that can be handled on the same scale at all facilities conducting nuclear medicine examinations and imaging. Hence, PIQE may be an efficient image evaluation method.

The NIQE results showed no correlation with the visual evaluation results. This could be because NIQE is a supervised method that employs a learning model using natural scene statistics [17].

Similar to natural images, PET images follow the Poisson distribution for image generation [32]. Because no-reference quality metrics match subjective human quality scores over fully referenced quality metrics, PET image evaluation using a no-reference metric was expected to be useful. This is another reason why PIQE is more consistent with visual evaluation than NIQE.

Numerical evaluation plays an important role in the image evaluation and medical treatment fields [33, 34]. Studies have conducted various evaluations without setting a gold standard. While various evaluation methods exist without setting a gold standard, methods without reference images are expected to gain wider acceptance for scoring and ranking image quality in the future [35, 36].

Despite its strengths, this study had limitations, notably the absence of clinical imaging based on brain phantom images. Nonetheless, our findings suggest that PIQE may be comparable to visual evaluation by radiologists and specialists, offering potential applications in clinical image evaluation across various anatomical regions.

Conclusions

In conclusion, this study investigated the application of no-reference metrics, specifically PIQE, in evaluating image quality for clinical images in nuclear medicine. The results demonstrate that PIQE evaluations align closely with visual evaluations by specialists, suggesting its potential as a reliable method for clinical image quality assessment. Moving forward, additional research and validation are warranted to fully integrate no-reference metrics into routine clinical practice in nuclear medicine.

Acknowledgments

We are grateful to the radiological technicians at the Department of Radiology, Osaka Metropolitan University Hospital.

Data Availability

All relevant data are within the paper.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Ueda D., Katayama Y., Yamamoto A., Ichinose T., Arima H., Watanabe Y., et al. Deep Learning–based angiogram generation model for cerebral angiography without misregistration artifacts. Radiology. 2021; 299(3): 675–681. doi: 10.1148/radiol.2021203692 [DOI] [PubMed] [Google Scholar]
  • 2.Zhu X., Cheng Y., Peng J., Wang R., Le M., & Liu X. Super-Resolved Image Perceptual Quality Improvement via Multi-Feature Discriminators. Computer Vision and Pattern Recognition. 2019. doi: 10.1117/1.JEI.29.1.013017 [DOI] [Google Scholar]
  • 3.Blau Y., Mechrez R., Timofte R., Michaeli T., & Zelnik-Manor L. The 2018 PIRM Challenge on Perceptual Image Super-resolution. arXiv:1809.07517v3 [cs.CV]. 2019. [Google Scholar]
  • 4.Blau Y., & Michaeli T. The Perception-Distortion Tradeoff. arXiv:1711.06077v4 [cs.CV]. 2020. doi: 10.1109/CVPR.2018.00652 [DOI] [Google Scholar]
  • 5.Yu Z., Rahman M. A., Schindler T. H., Gropler R. J., Laforest R., Wahl R. L., et al. Need for Objective Task-based Evaluation of Deep Learning-Based Denoising Methods: A Study in the Context of Myocardial Perfusion SPECT. Journal of Nuclear Medicine. 2020; 61(supplement 1): 575. doi: 10.48550/arXiv.2303.02110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kabasakal L., Devos A., Fettich J., Franken P., Guilloteau D., Hustinx R., et al. Optimum tomographic reconstruction parameters for HMPAO brain SPET imaging: a practical approach based on subjective and objective indexes. European Journal of Nuclear Medicine. 1995; 22(8): 671–677. 10.1007/BF01254569. [DOI] [PubMed] [Google Scholar]
  • 7.Okuda K., Fujii S., & Sakimoto S. Impact of Novel Incorporation of CT-based Segment Mapping into a Conjugated Gradient Algorithm on Bone SPECT Imaging: Fundamental Characteristics of a Context-specific Reconstruction Method. Asia Oceania Journal of Nuclear Medicine & Biology. 2019; 7(1): 49–57. 10.22038/aojnmb.2018.31711.1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Händel P. Understanding Normalized Mean Squared Error in Power Amplifier Linearization. IEEE Microwave and Wireless Components Letters. 2018; 28(11): 1047–1049. 10.1109/LMWC.2018.2869299. [DOI] [Google Scholar]
  • 9.Akamatsu M., Yamashita Y., Akamatsu G., Tsutsui Y., Ohya N., Nakamura Y., et al. Influences of reconstruction and attenuation correction in brain SPECT images obtained by the hybrid SPECT/CT device: evaluation with a 3-dimensional brain phantom. Asia Oceania Journal of Nuclear Medicine & Biology. 2015; 2(1): 24–29. 10.7508/aojnmb.2014.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Abe K., Hosono M., Igarashi T., Iimori T., Ishiguro M., Ito T., et al. The 2020 national diagnostic reference levels for nuclear medicine in Japan. Annals of Nuclear Medicine. 2020; 34(11): 799–806. doi: 10.1007/s12149-020-01512-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Raunig D. L., McShane L. M., Pennello G., Gatsonis C., Carson P. L., Voyvodic J. T., et al. Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment. Statistical Methods in Medical Research. 2015; 24(1): 27–67. doi: 10.1177/0962280214537344 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Aide N., Lasnon C., Veit-Haibach P., Sera T., Sattler B., & Boellaard R. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. European Journal of Nuclear Medicine and Molecular Imaging. 2017; 44: S17–S31. doi: 10.1007/s00259-017-3740-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Varrone A., Asenbaum S., Vander Borght T., Booij J., Nobili F., Någren K., et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. European Journal of Nuclear Medicine and Molecular Imaging. 2009; 36: 2103–2110. doi: 10.1007/s00259-009-1264-0 [DOI] [PubMed] [Google Scholar]
  • 14.Boellaard R., Delgado-Bolton R., Oyen W. J. G., Giammarile F., Tatsch K., Eschner W., et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. European Journal of Nuclear Medicine and Molecular Imaging. 2015; 42(3): 328–354. doi: 10.1007/s00259-014-2961-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Venkatanath N., Praneeth D., Maruthi Chandrasekaran B., Sumohana Channappayya S., & Medasani S. S. Blind image quality evaluation using perception based features. In 2015 Twenty First National Conference on Communications (NCC). 2015. 10.1109/NCC.2015.7084843. [DOI] [Google Scholar]
  • 16.Mittal A., Moorthy A. K., & Bovik A. C. No-reference image quality assessment in the spatial domain. IEEE Transactions on Image Processing. 2012; 21(12): 4695–4708. doi: 10.1109/TIP.2012.2214050 [DOI] [PubMed] [Google Scholar]
  • 17.Mittal A., Soundararajan R., & Bovik A. C. Making a “completely blind” image quality analyzer. IEEE Signal Processing Letters. 2013; 20(3): 209–212. 10.1109/LSP.2012.2227726. [DOI] [Google Scholar]
  • 18.Japanese Society of Nuclear Medicine, PET Nuclear Medicine Committee. (2021). Phantom Testing Procedures for Brain PET Imaging Using 18F-FDG and Amyloid Imaging Agents, 5th Edition. Version 2021/2/8. https://jsnm.org/wp_jsnm/wp-content/uploads/2021/02/Dementia_PhantomTest_20210208.pdf. [Google Scholar]
  • 19.Fahey F. H., Clark P., Zukotynski K., Schuster D. M., Strauss K. J., Crandall B., et al. Use of a qualification phantom for PET brain imaging in a multicenter consortium: A collaboration between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network. Journal of Nuclear Medicine. 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Seret J., Imbert L., Pietquin M., Karcher G., Lamiral Z., & Marie P.-Y. Head-to-head comparison of image quality between brain 18F-FDG images recorded with a fully digital versus a last-generation analog PET camera. EJNMMI Research. 2019; 9(1): 61. doi: 10.1186/s13550-019-0526-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Bradley T. C., & Lang P. J. Measuring emotion: The Self-Assessment Manikin and the Semantic Differential. Journal of Behavior Therapy and Experimental Psychiatry. 1994; 25(1): 49–59. doi: 10.1016/0005-7916(94)90063-9 [DOI] [PubMed] [Google Scholar]
  • 22.McDermott G. M., Chowdhury F. U., & Scarsbrook A. F. Evaluation of noise equivalent count parameters as indicators of adult whole-body FDG-PET image quality. Annals of Nuclear Medicine. 2013; 27(8): 855–861. doi: 10.1007/s12149-013-0760-2 [DOI] [PubMed] [Google Scholar]
  • 23.Treglia G., Bertagna F., Sadeghi R., Ceriani L., Alavi A., & Giovanella L., et al. Diagnostic value of FDG PET-CT quantitative parameters and Deauville-like 5 point-scale in predicting malignancy of focal thyroid incidentaloma. Frontiers in Medicine. 2019; 6: 24. doi: 10.3389/fmed.2019.00024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chani J. C. C., Fager C., & Eriksson T. Lower bound for the normalized mean square error in power amplifier linearization. IEEE Microwave and Wireless Components Letters. 2018; 28(5): 435–437. 10.1109/LMWC.2018.2817021. [DOI] [Google Scholar]
  • 25.Sheikh H. R., Sabir M. F., & Bovik A. C. A statistical evaluation of recent full reference image quality assessment algorithms. IEEE Transactions on Image Processing. 2006; 15(11): 3440–3451. doi: 10.1109/tip.2006.881959 [DOI] [PubMed] [Google Scholar]
  • 26.Marziliano P., Dufaux F., Winkler S., & Ebrahimi T. Perceptual blur and ringing metrics: application to JPEG2000. Signal Processing: Image Communication. 2004; 19(2): 163–172. 10.1016/j.image.2003.08.003. [DOI] [Google Scholar]
  • 27.Sheikh H. R., Bovik A. C., & Cormack L. No-reference quality assessment using natural scene statistics: JPEG2000. IEEE Transactions on Image Processing. 2005; 14(11): 1918–1927. doi: 10.1109/tip.2005.854492 [DOI] [PubMed] [Google Scholar]
  • 28.Cottereau N., Meignan M., Cottereau A. S., Becker S., Alavi A., & Stolz C., et al. Deep-learning 18F-FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma. Journal of Nuclear Medicine. 2021; 62(1): 30–36. doi: 10.2967/jnumed.120.242412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gifford H. C., King M. A., de Vries D. J., & Soares E. J. Channelized hotelling and human observer correlation for lesion detection in hepatic SPECT imaging. Journal of Nuclear Medicine. 2000; 41(3): 514–521. [PubMed] [Google Scholar]
  • 30.Boellaard Ronald. Standards for PET Image Acquisition and Quantitative Data Analysis. Journal of Nuclear Medicine 2009; 50: 11–20. doi: 10.2967/jnumed.108.057182 [DOI] [PubMed] [Google Scholar]
  • 31.Marinke W., Jan P., Wim O., Otto H., Anne P., Eric V., et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction,resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging (2007) 34:392–404. doi: 10.1007/s00259-006-0224-1 [DOI] [PubMed] [Google Scholar]
  • 32.Van Slambrouck K., Stute S., Comtat C., Sibomana M., & van Velden F. H. P., et al. Bias reduction for low-statistics PET: Maximum likelihood reconstruction with a modified Poisson distribution. IEEE Transactions on Medical Imaging. 2015; 34(1): 126–136. doi: 10.1109/TMI.2014.2347810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Almeida B. A. L. C., Rodrigues H. L.d. N. R., Almeida P. L., Araújo S. M. A. J. Immediate effect of ankle mobilization on range of motion, dynamic knee valgus, and knee pain in women with patellofemoral pain and ankle dorsiflexion restriction: A randomized controlled trial with 48-hour follow-up. Journal of Sport Rehabilitation. 2021; 30: doi: 10.1123/jsr.2020-0183 [DOI] [PubMed] [Google Scholar]
  • 34.Zhang, J. Making diagnoses with multiple tests under no gold standard. Retrieved from Iowa Research Online: https://ir.uiowa.edu/etd/3025. 2012. 10.17077/etd.wq3qkdxu. [DOI]
  • 35.Kijowski M. A., Wilson J. J., Klaers J., Spector D., Fine J. P., King M. A., et al. Comparing cardiac ejection fraction estimation algorithms without a gold standard. Academic Radiology. 2006; 13(3): 329–337. doi: 10.1016/j.acra.2005.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Liu J., Liu Z., Mhlanga J., Siegel B. A., & Jha A. K. A no-gold-standard technique to objectively evaluate quantitative imaging methods using patient data: Theory. Medical Physics. 2020. arXiv:2006.02290. 10.48550/arXiv.2006.02290. [DOI] [Google Scholar]

Decision Letter 0

Sadiq H Abdulhussain

15 Mar 2024

PONE-D-23-28461Investigation of the effectiveness of No-reference Metric in Image evaluation in Nuclear MedicinePLOS ONE

Dear Dr. Higashiyama,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 28 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sadiq H. Abdulhussain, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ".

5. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

6. We note that Figure 1 and 4 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1. You may seek permission from the original copyright holder of Figure 1 and 4 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: This paper examines whether No-Reference metrics can be applied to image quality evaluations for clinical images in nuclear medicine. To this end, 14 images with different numbers of pixels and acquisition times were created and extracted from Biograph Vision. The paper is well organized but not well written. I have some minor points that need to be addressed.

1. The contribution is not clear and needs to be highlighted.

2. The introduction should be modified so that the last paragraphs should be divided as paper contributions and finds and paper organization as a separated subsections.

3. Please make the contributions as a bullet points.

4. The novelty of the paper needs to be modified to be more clear.

5. Some grammar errors are discovered so please try to proofread the paper again.

6. I would suggest make it clear what have been done in comparison to the state of the art methods showing the contribution of the paper.

7. I would suggest adding equation number.

8. I have found that there is an evaluation before the results section. I would suggest making the evaluation in results section part to make it clear to the reader.

9. The author state that (The total score in shown in bottom row of..) what dose that means please correct.

10. Tables should not be splatted into two pages please correct table 14.

11. There are many references in the discussion part after the results. Why not stated these references in the introduction part.

12. The conclusion is too short and not clear please modify.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: None

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Comments to the author_ Plose one.docx

pone.0310305.s001.docx (14.7KB, docx)
PLoS One. 2024 Nov 21;19(11):e0310305. doi: 10.1371/journal.pone.0310305.r002

Author response to Decision Letter 0


4 Apr 2024

Thank you for your careful review and your comments.

We have made changes to comply with your suggestions. The revised parts of the manuscript are written in red.

Journal Requirements:

1 When submitting your revision, we need you to address these additional requirements.

→We have made the changes according to your suggestions.

2 Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience.

→ We have read and understood the contents.

3 Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work.

→ We have read and understood the contents.

4 PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016.

→ The authors and corresponding author (Shigeaki Higashiyama) are registered ORCID members.

5 We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

→ All relevant data are present in the manuscript and Supporting Information files.

6 We note that Figure 1 and 4 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

→ Figures 1 and 4 are images that I created and used in this paper. This is not a quotation from any literature or book. I had inquired about permission to use the preprint without peer review, but I received a reply stating that there was no need to confirm the license. I have added that email as a PDF attachment to the other file.

Comments to the Author 

1-3 and 6 → We do not require a response.

4→ We utilized a paid English proofreading of the main text. Certificate of editing was attached the file as PDF.

5 Review Comments to the Author

To Reviewer #1: (No Response)

To Reviewer #2

1、 The contribution is not clear and needs to be highlighted.

→ We have modified the introduction to include a subsection specifically dedicated to outlining the contributions and findings of the paper.

2、The introduction should be modified so that the last paragraphs should be divided as paper contributions and finds and paper organization as a separated subsections.

→ We divided the Introduction into paragraphs on Contributions and findings.

3 Please make the contributions as a bullet points.

→ We divided the Introduction and Abstract into paragraphs and clearly stated the novelty.

4、The novelty of the paper needs to be modified to be more clear.

→ A sentence explaining the novelty of this research has been added to the introduction.

5、Some grammar errors are discovered so please try to proofread the paper again.

→ We have used a paid English proofreading service. Certificate of editing was attached the file as PDF.

6、 I would suggest make it clear what have been done in comparison to the state of the art methods showing the contribution of the paper.

→ In the introduction, we have added a description on the novel aspects of this study compared to what has been presented in past papers.

7、 I would suggest adding equation number.

→ We have numbered the equations in the text.

8、 I have found that there is an evaluation before the results section. I would suggest making the evaluation in results section part to make it clear to the reader.

→ Based on you suggestion, we have made changes to make the results easier to understand.

9、The author state that (The total score in shown in bottom row of..) what dose that means please correct.

→ We have added a description of the table you pointed out.

10、 Tables should not be splatted into two pages please correct table 14.

→ We have accordingly reorganized Table 14.

11、There are many references in the discussion part after the results. Why not stated these references in the introduction part.

→ Some of the references for the discussion are cited in the methods section.

12、The conclusion is too short and not clear please modify.

→As pointed out, I have further elaborated the content in the conclusion section.

Attachment

Submitted filename: 20240329Journal Requirements and review comments.docx

pone.0310305.s002.docx (17.7KB, docx)

Decision Letter 1

Sadiq H Abdulhussain

24 Jun 2024

PONE-D-23-28461R1Investigation of the Effectiveness of No-reference Metric in Image Evaluation in Nuclear MedicinePLOS ONE

Dear Dr. Higashiyama,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 08 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sadiq H. Abdulhussain, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments:

The authors are asked to check the attached files for reviewer comments.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: All the comments have been addressed. The authors modified the paper based on the suggested comment. Iwouls suggest accept this paper.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Point.docx

pone.0310305.s003.docx (13.3KB, docx)
PLoS One. 2024 Nov 21;19(11):e0310305. doi: 10.1371/journal.pone.0310305.r004

Author response to Decision Letter 1


26 Jun 2024

Response to Reviewers

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response) → We have corrected the points raised in the point by point response.

Reviewer #2: All comments have been addressed → Thank you for reviewing the revised manuscript.

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly → Thank you for reviewing the revised manuscript. We have corrected the points raised in the point by point response.

Our study uses phantom data that is accessible from any research institution, not patient clinical data. Therefore, reproducing the methods described in the manuscript is feasible and technically sound. Consequently, we believe that faithfully replicating the methods and evaluation criteria of this paper allows for accurate replication of the conclusions presented in the manuscript. As such, no changes or additions to the evaluation methods or data have been made.

Reviewer #2: Yes → Thank you for reviewing the revised manuscript.

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know → We have corrected the points raised in the point by point response. Our study employed JMP (SAS Japan Co., Ltd) for statistical analysis. Therefore, the statistical analysis in the manuscript is replicable, and technically robust.

Reviewer #2: Yes → Thank you for reviewing the revised manuscript.

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes →Thank you for reviewing the revised manuscript.

Reviewer #2: Yes →Thank you for reviewing the revised manuscript.

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No →We have corrected the points raised in the point by point response.  In addition, we have followed the points raised in the first peer review. We have engaged a professional medical manuscript editing service to revise the manuscript at our own expense. The revised manuscript, addressing these comments, is now submitted. If there are any parts that do not conform to standard English, please provide specific feedback, and we will promptly make corrections.

Certificate of English ProofreadingHonyaku Center Inc. certifies that the manuscript entitled

Investigation of the Effectiveness of No-reference Metric in Image Evaluation in Nuclear Medicine

has been edited and corrected to the highest standards.

Neither the contents of this manuscript nor the author’s intentions have been altered in any way.

This manuscript has been edited and corrected by an experienced proofreader who is a native speaker of

English and who is under the direct supervision of Honyaku Center Inc.

ISSUED ON March 28, 2024 AUTHORS Shigeaki Higashiyama JOB CODE BQYRQ_2 Yasuo Terashima

Reviewer #2: Yes →Thank you for reviewing the revised manuscript. We will proceed with the submission as it is.

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)  →Thank you for reviewing the revised manuscript. We will proceed with the submission as it is.

Reviewer #2: All the comments have been addressed. The authors modified the paper based on the suggested comment. Iwouls suggest accept this paper.  →Thank you for reviewing the revised manuscript. We will proceed with the submission as it is.

Point-by-point response

・98: 2 6 MBq basis for inclusion.

⇒The Japanese Society of Nuclear Medicine has publicly released a procedure manual for phantom tests. We used the radiation dose from the FDG and Amyloid Brain PET Imaging Phantom Test Procedure Manual (in Japanese). https://jsnm.org/wp_jsnm/wp-content/uploads/2021/02/Dementia_PhantomTest_20210208.pdf

・99:PET/CT scannerのBiograph visionは450?600?

・99: The PET/CT scanner used was the Biographic vision 450 or 600?

⇒ We have made changes to lines 86 and 97.

・112:Pixel size 0.825 mm is only correct for a matrix size of 880 when the transverse FOV is 726 mm.

⇒ With an FOV of 363 mm, for a Matrix Size of 440, the voxel size becomes 0.825 mm.

We have added a description of the FOV in the 99th line.

・113: Is 3 mm correct for Slice thickness instead of 3 cm?

⇒ We have made changes to lines 101.

116: Imaging conditions for computed tomography attenuation correction should be stated.

  The description of Random correction should also be added.

⇒ We have described the reconstruction conditions using CT and the random correction in lines 104 and 111.

・120: 440 matrix size is more appropriate than 440 pixel size.

⇒ We have made changes to lines 109,110.

:What does 0.4125 mm×0.4125×2 mm3mean? If the transverse FOV is 726 mm and the matrix size is 440, the pixel size is 1.65 mm; if the matrix size is 880, the pixel size is 0.825 mm. If the magnification factor is 2x, the pixel size is 0.825 mm for a 440 matrix size and 0.4125 for an 880 matrix size.

⇒ The FOV is 363 mm. We have added this to line 100.

・122: Statistical analysis instruments are described, but significance levels are not stated. 

⇒ We have added p-value settings to lines 217 and 220.

・235:CV should be assessed on a uniform phantom. There is also poor evidence for the size and location of the ROI; if CV is measured once in each series, it should be measured at least three times to account for measurement error.

⇒ We evaluate with ROIs of 5 mm diameter when conducting clinical image evaluations at our facility. In line with that evaluation method, we conducted evaluations using ROIs of 5 mm diameter. This information has been added to line 226.

⇒ We did not conduct experiments with a pool phantom because we aimed for evaluations based on images intended for clinical examinations.

・394: acquisition time is appropriate, not capturing time.

⇒ We have made changes to lines 381.

・The matrix size and color scale should be added to Fig 1 and Fig 2 respectively.

⇒We have modified lines 566 to 572.

・The names of the vertical axes in Fig 6 should be added.

⇒ We have made corrections to lines 218 to 221 and added them to Fig. 6.

・The names of the vertical and horizontal axes in Figure 8 are mandatory. If the vertical axis is the CV value and the horizontal axis is the acquisition time, they should be described.

⇒We have made modifications to Figure 8.

・Is the value obtained for the 440 and 880 matrix size for 330 s in the CV results in Table 4 correct?

⇒Thank you very much for your detailed feedback. There are no mistakes in the parts you pointed out, and the results are accurate.

・The CV values were similar for the 880 matrix size and the 440 matrix size. However, the visual evaluation results show that the 880 matrix size is better for all acquisition time when compared to the 440 matrix size.

⇒Thank you very much for your detailed feedback. There are no mistakes in the parts you pointed out, and the results are accurate.

Attachment

Submitted filename: 20240624Response to Reviewers.docx

pone.0310305.s004.docx (21.7KB, docx)

Decision Letter 2

Sadiq H Abdulhussain

6 Aug 2024

PONE-D-23-28461R2Investigation of the Effectiveness of No-reference Metric in Image Evaluation in Nuclear MedicinePLOS ONE

Dear Dr. Higashiyama,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Please submit your revised manuscript by Sep 20 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sadiq H. Abdulhussain, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer Comments.docx

pone.0310305.s005.docx (15.3KB, docx)
PLoS One. 2024 Nov 21;19(11):e0310305. doi: 10.1371/journal.pone.0310305.r006

Author response to Decision Letter 2


7 Aug 2024

Thank you for your careful review and your comments.

We have made changes to comply with your suggestions.

Changed parts are written in red.

Reviewer Comments

84:Additional references to the guidelines.

→References have been added and additional information has been added.

100, 112, 113, 115:Half-width space added between number and unit.

→We made the changes as you suggested.

125: 880 matrix size is more correct than 880 pixels. Please check the other text as well; Fig. 1a should be a PET image with 440 matrix size, not 440 s.

→We made the changes as you suggested.

We evaluate with ROIs of 5 mm diameter when conducting clinical image evaluations

at our facility.

⇒ In the diagnostic imaging, it is necessary to state the validity of the 'method of placing a 5 mm ROI on the brain PET image', as shown in Fig. 4. For example, the rationale based on guidelines and previous studies.

→References have been added and additional information has been added.

The number of measurements should be performed at least three times due to the variability of the data.

→ To check the variability of the data, we examined it in three locations: the frontal lobe, the temporal lobe, and the occipital lobe. Changes and additions to the table and figure have been added at lines 226、331 and 387.

Addition of units for acquisition time in Fig. 8.

→We made the changes as you suggested.

Attachment

Submitted filename: 20240808Reviewer Comments.docx

pone.0310305.s006.docx (17.1KB, docx)

Decision Letter 3

Sadiq H Abdulhussain

29 Aug 2024

Investigation of the Effectiveness of No-reference Metric in Image Evaluation in Nuclear Medicine

PONE-D-23-28461R3

Dear Dr. Higashiyama,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sadiq H. Abdulhussain, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

**********

Acceptance letter

Sadiq H Abdulhussain

16 Sep 2024

PONE-D-23-28461R3

PLOS ONE

Dear Dr. Higashiyama,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Sadiq H. Abdulhussain

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Comments to the author_ Plose one.docx

    pone.0310305.s001.docx (14.7KB, docx)
    Attachment

    Submitted filename: 20240329Journal Requirements and review comments.docx

    pone.0310305.s002.docx (17.7KB, docx)
    Attachment

    Submitted filename: Point.docx

    pone.0310305.s003.docx (13.3KB, docx)
    Attachment

    Submitted filename: 20240624Response to Reviewers.docx

    pone.0310305.s004.docx (21.7KB, docx)
    Attachment

    Submitted filename: Reviewer Comments.docx

    pone.0310305.s005.docx (15.3KB, docx)
    Attachment

    Submitted filename: 20240808Reviewer Comments.docx

    pone.0310305.s006.docx (17.1KB, docx)

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES